Viscosupplementation in the Therapy for Osteoarthritic Knee
Source abstract
Abstract
Osteoarthritis (OA) is a degenerative disease that is spreading worldwide due to an aging population. This is not simply a disease caused by worn out joints, but a complex disease accompanied by various mechanisms such as inflammatory reactions. Among various joints, knee joints show degenerative changes earlier than other joints because they carry most of the weight load, causing social-economic problems. In the case of OA of the knee that does not respond to relatively simple conservative treatments such as physical therapy or medication, intra-articular injection is preferred. However, intra-articular injection drugs have limited effectiveness and uncertainties. There are several intra-articular viscous supplement drugs such as hyaluronic acid. Tissue regeneration active materials such as polydeoxyribonucleotide and polynucleotide are also newly used. The objective of this paper was to compare effects of intra-articular supplementation drugs used for degenerative arthritis of the knee.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Knee injuries and reconstruction techniques · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Anesthesiology and Pain Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon 21431, Korea
Department of Anesthesiology and Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
References (100+)
Show source-provided references
1. Castrogiovanni, P., Trovato, F.M., Loreto, C., Nsir, H., Szychlinska, M.A., and Musumeci, G. (2016). Nutraceutical supplements in the management and prevention of osteoarthritis. Int. J. Mol. Sci., 17.10.3390/ijms17122042 ↗
2. Vital signs: Prevalence of doctor-diagnosed athritis and arthritis-attributable activity limitation—United States, 2013–201510.15585/mmwr.mm6609e1 ↗
3. Clinical settings in knee osteoarthritis: Pathophysiology guides treatment10.1016/j.maturitas.2016.11.013 ↗
4. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines10.1016/j.joca.2007.12.013 ↗
5. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part two: Strengthening exercise programs10.1177/0269215517691084 ↗
6. Testa, G., Giardina, S.M.C., Culmone, A., Vescio, A., Turchetta, M., Cannavò, S., and Pavone, V. (2021). Intra-Articular Injections in Knee Osteoarthritis: A Review of Literature. J. Funct. Morphol. Kinesiol., 6.10.3390/jfmk6010015 ↗
7. Advances of hyaluronic acid in stem cell therapy and tissue engineering, including current clinical trials10.22203/eCM.v037a12 ↗
8. Intra-articular treatment with sodium hyaluronate in gonarthrosis: A controlled clinical trial versus placebo
9. Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate
10. Intra-articular sodium hyaluronate in osteoarthritis of the knee: A multicenter, double-blind study10.1016/S1063-4584(05)80329-2 ↗
11. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: A randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy10.1136/ard.53.8.529 ↗
12. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis10.1016/S1063-4584(05)80018-4 ↗
13. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group10.1136/ard.55.7.424 ↗
14. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. Hyalgan Study Group
15. Hyaluronic acid in the treatment of osteoarthritis of the knee10.1093/rheumatology/38.7.602 ↗
16. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group10.1097/00003086-200104000-00021 ↗
17. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled clinical trial10.1001/archinte.162.3.292 ↗
18. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee10.1111/j.1742-1241.2003.tb10535.x ↗
19. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee
20. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: A randomized, controlled, multicenter trial
21. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee
22. Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain10.1016/j.apmr.2006.11.006 ↗
23. Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: A pilot randomized double-blind placebo-controlled trial10.1186/1475-2891-7-3 ↗
24. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial)10.1016/j.semarthrit.2009.04.001 ↗
25. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: A multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year
26. Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: Prospective randomized study of sodium hyaluronate and corticosteroid10.1007/s00776-009-1421-0 ↗
27. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: The AMELIA project10.1136/ard.2011.152017 ↗
28. Huang, T.L., Chang, C.C., Lee, C.H., Chen, S.C., Lai, C.H., and Tsai, C.L. (2011). Intra-articular injections of sodium hyaluronate (Hyalgan) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord., 12.10.1186/1471-2474-12-221 ↗
29. The effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: A randomized, controlled study10.1016/j.archger.2011.11.007 ↗
30. Intra-articular hylastan versus steroid for knee osteoarthritis10.1007/s00167-013-2438-7 ↗
31. Research Group of Cartilage Metabolism. Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: A multi-center, randomized, open-label, non-inferiority trial10.1186/ar4446 ↗
32. No difference between intra-articular injection of hyaluronic acid and placebo for mild to moderate knee osteoarthritis: A randomized, controlled, double-blind trial10.1016/j.arth.2014.12.012 ↗
33. Viscosupplementation improves pain, function and muscle strength, but not proprioception, in patients with knee osteoarthritis: A prospective randomized trial10.6061/clinics/2019/e1207 ↗
34. Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials10.1016/j.semarthrit.2016.04.003 ↗
35. Viscosupplementation for the treatment of osteoarthritis of the knee
36. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: Changes in evidence following systematic cumulative update of research published through January 200910.1016/j.joca.2010.01.013 ↗
37. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis10.1016/j.joca.2010.09.014 ↗
38. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: A systematic review and network meta-analysis10.7326/M14-1231 ↗
39. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting10.1016/j.semarthrit.2015.11.010 ↗
40. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses10.1016/j.arthro.2015.03.030 ↗
41. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: A systematic review and meta-analysis of randomized, saline-controlled trials
42. Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: A Canadian evidence-based perspective10.1177/1759720X17729641 ↗
43. Comparison of intra-articular hyaluronic acid and methylprednisolone for pain management in knee osteoarthritis: A meta-analysis of randomized controlled trials10.1016/j.ijsu.2018.02.065 ↗
44. Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review10.1016/j.semarthrit.2018.06.002 ↗
45. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis10.1016/j.joca.2019.06.011 ↗
46. The Impact of Excluding Patients with End-Stage Knee Disease in Intra-Articular Hyaluronic Acid Trials: A Systematic Review and Meta-Analysis10.1007/s12325-018-0847-1 ↗
47. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)10.1016/j.semarthrit.2019.04.008 ↗
48. Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time Horizon10.1007/s40265-020-01423-8 ↗
49. Injections in the osteoarthritic knee: A review of current treatment options10.1302/2058-5241.6.210026 ↗
50. One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: A systematic literature review and meta-analysis10.1007/s10067-020-05477-7 ↗
51. Injection-Based Management of Osteoarthritis of the Knee: A Systematic Review of Guidelines10.3389/fphar.2021.661805 ↗
52. Intra-Articular Injections of Hyaluronic Acid or Steroids Associated with Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis10.1016/j.arthro.2020.03.041 ↗
53. Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis10.7326/0003-4819-157-3-201208070-00473 ↗
54. Hyaluronic acid intra-articular injection and exercise therapy: Effects on pain and disability in subjects affected by lower limb joints osteoarthritis. A systematic review by the Italian Society of Physical and Rehabilitation Medicine (SIMFER)
55. The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies10.1177/0363546516680607 ↗
56. Intra-articular treatment options for knee osteoarthritis10.1038/s41584-018-0123-4 ↗
57. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee10.1002/acr.24131 ↗
58. AAOS clinical practice guideline: Treatment of osteoarthritis of the knee: Evidence-based guideline, 2nd edition
59. Osteoarthritis of the Knee10.1056/NEJMcp1903768 ↗
60. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys10.1016/j.semarthrit.2015.11.008 ↗
61. Evidence and recommendations for use of intra-articular injections for knee osteoarthritis10.1016/j.rehab.2016.02.008 ↗
62. Recent advances in hyaluronic acid based therapy for osteoarthritis10.1186/s40169-017-0180-3 ↗
63. Hyaluronidases: Their genomics, structures, and mechanisms of action10.1021/cr050247k ↗
64. Osteoarthritis Group of the French Society of Rheumatology. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study10.1002/jor.21580 ↗
65. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500–730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee10.1053/joca.2000.0398 ↗
66. Nonoperative treatment of unicompartmental arthritis: From bracing to injection10.1016/j.csm.2013.08.002 ↗
67. Intra-articular hyaluronans: The treatment of knee pain in osteoarthritis10.2147/JPR.S4733 ↗
68. Effect of intra-articular hyaluronic injection on postural stability and risk of fall in patients with bilateral knee osteoarthritis10.1155/2014/815184 ↗
69. Viscosupplementation: Techniques, indications, results10.1016/j.otsr.2014.07.027 ↗
70. Hyaluronic acid-based products are strictly contraindicated in scleroderma-related skin ulcers
71. Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis10.1002/jor.23529 ↗
72. Septic Arthritis after Intra-articular Hyaluronic Acid Injections in Patients with Knee Osteoarthritis-A report of two cases
73. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis10.1016/j.ijsu.2017.01.087 ↗
74. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study10.1016/j.joca.2011.07.016 ↗
75. Yoshioka, K., Katayama, M., Nishiyama, T., Harada, K., Takeshita, S., and Kawamata, Y. (2019). Biocompatibility study of different hyaluronan products for intra-articular treatment of knee osteoarthritis. BMC Musculoskelet Disord., 20.10.1186/s12891-019-2815-6 ↗
76. Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee10.1177/0363546515609599 ↗
77. Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial10.1016/j.knee.2016.05.015 ↗
78. Efficacy and safety of a single intra-articular injection of 2% hyaluronic acid plus mannitol in knee osteoarthritis over a 6-month period
79. Is the Addition of a Polyol to Hyaluronic Acid a Significant Advance in the Treatment of Osteoarthritis?10.2174/1573397113666170710115558 ↗
80. Zhang, Z., Wei, X., Gao, J., Zhao, Y., Zhao, Y., Guo, L., Chen, C., Duan, Z., Li, P., and Wei, L. (2016). Intra-Articular Injection of Cross-Linked Hyaluronic Acid-Dexamethasone Hydrogel Attenuates Osteoarthritis: An Experimental Study in a Rat Model of Osteoarthritis. Int. J. Mol. Sci., 17.10.3390/ijms17040411 ↗
81. Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial10.1177/1947603517703732 ↗
82. Effectiveness of 3 Weekly Injections Compared With 5 Weekly Injections of Intra-Articular Sodium Hyaluronate on Pain Relief of Knee Osteoarthritis or 3 Weekly Injections of Other Hyaluronan Products: A Systematic Review and Meta-Analysis10.1016/j.apmr.2017.01.021 ↗
83. Concoff, A., Sancheti, P., Niazi, F., Shaw, P., and Rosen, J. (2017). The efficacy of multiple versus single hyaluronic acid injections: A systematic review and meta-analysis. BMC Musculoskelet Disord., 18.10.1186/s12891-017-1897-2 ↗
84. Randomized controlled trial comparing efficacy of conventional and new single larger dose of intra-articular viscosupplementation in management of knee osteoarthritis10.1177/2309499017731627 ↗
85. Bahrami, M.H., Raeissadat, S.A., Cheraghi, M., Rahimi-Dehgolan, S., and Ebrahimpour, A. (2020). Efficacy of single high-molecular-weight versus triple low-molecular-weight hyaluronic acid intra-articular injection among knee osteoarthritis patients. BMC Musculoskelet Disord., 21.10.1186/s12891-020-03577-8 ↗
86. Ha, C.W., Park, Y.B., Choi, C.H., Kyung, H.S., Lee, J.H., Yoo, J.D., Yoo, J.H., Choi, C.H., Kim, C.W., and Kim, H.C. (2017). Efficacy and safety of single injection of cross-linked sodium hyaluronate vs. three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: A double-blind, randomized, multi-center, non-inferiority study. BMC Musculoskelet Disord., 18.10.1186/s12891-017-1591-4 ↗
87. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone10.1016/S1063-4584(05)80013-5 ↗
88. Viscosupplementation with hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee10.1016/S0149-2918(98)80052-0 ↗
89. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: A comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan10.1016/S0149-2918(00)80010-7 ↗
90. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study10.1093/rheumatology/41.11.1240 ↗
91. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial10.2106/00004623-200307000-00003 ↗
92. Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee10.1016/j.joca.2004.04.010 ↗
93. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee
94. Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis10.1007/s10067-004-1077-2 ↗
95. Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up
96. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial10.1002/art.23026 ↗
97. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: A randomised, multicentre, double-blind, placebo controlled trial10.1136/ard.2008.094623 ↗
98. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee10.1016/j.joca.2012.01.013 ↗
99. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain
100. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis10.1185/03007995.2013.855631 ↗